Variant report

Variant	nsv965224
Chromosome Location	chr3:154798636-154801821
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:154797474-154798778	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr3:154800540-154800690	HRPEpiC	eye:	n/a	n/a
3	CTCF	chr3:154800400-154800550	AG04450	lung:	n/a	n/a
4	CTCF	chr3:154798500-154798650	HCPEpiC	choroid plexus:	n/a	n/a
5	CTCF	chr3:154800220-154800370	NHDF-neo	bronchial:	n/a	n/a
6	CTCF	chr3:154800280-154800430	HMF	breast:	n/a	n/a
7	CTCF	chr3:154800280-154800430	HVMF	connective:	n/a	n/a
8	CTCF	chr3:154800220-154800370	MCF-7	breast:	n/a	n/a
9	CTCF	chr3:154800220-154800370	HRPEpiC	eye:	n/a	n/a
10	CTCF	chr3:154800180-154800330	HMEC	breast:	n/a	n/a
11	CTCF	chr3:154800340-154800490	NHEK	skin:	n/a	n/a
12	CTCF	chr3:154800280-154800430	HMEC	breast:	n/a	n/a
13	CTCF	chr3:154800200-154800350	AoAF	blood vessel:	n/a	n/a
14	CTCF	chr3:154800260-154800410	HPAF	blood vessel:	n/a	n/a
15	CTCF	chr3:154800200-154800350	HMF	breast:	n/a	n/a
16	CTCF	chr3:154800340-154800490	HEEpiC	esophagus:	n/a	n/a
17	CTCF	chr3:154800100-154800250	MCF-7	breast:	n/a	n/a
18	CTCF	chr3:154800240-154800390	HPAF	blood vessel:	n/a	n/a
19	CTCF	chr3:154800280-154800430	HRPEpiC	eye:	n/a	n/a
20	JUN	chr3:154799544-154799580	HepG2	liver:	n/a	n/a
21	JUND	chr3:154799468-154799601	H1-hESC	embryonic stem cell:	n/a	n/a
22	KAP1	chr3:154801051-154801457	K562	blood:	n/a	n/a
23	MAFF	chr3:154798483-154798708	K562	blood:	n/a	chr3:154798611-154798629 chr3:154798610-154798624
24	MAFF	chr3:154798462-154798765	HepG2	liver:	n/a	chr3:154798611-154798629 chr3:154798610-154798624
25	MAFK	chr3:154798475-154798788	HepG2	liver:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
26	MAFK	chr3:154798440-154799101	HepG2	liver:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
27	MAFK	chr3:154798010-154798784	H1-hESC	embryonic stem cell:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
28	MAFK	chr3:154798259-154799035	IMR90	lung:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
29	MAFK	chr3:154798426-154798838	K562	blood:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
30	MAFK	chr3:154798494-154798688	Hela-S3	cervix:	n/a	chr3:154798616-154798627 chr3:154798607-154798627 chr3:154798610-154798624 chr3:154798616-154798627 chr3:154798612-154798627 chr3:154798609-154798625
31	POLR2A	chr3:154797505-154798984	MCF10A-Er-Src	breast:	n/a	n/a
32	POLR2A	chr3:154795817-154801378	SK-N-SH	brain:	n/a	n/a
33	POLR2A	chr3:154801418-154801493	MCF10A-Er-Src	breast:	n/a	n/a
34	POLR2A	chr3:154796309-154799404	SK-N-SH	brain:	n/a	n/a
35	POLR2A	chr3:154800666-154800674	MCF10A-Er-Src	breast:	n/a	n/a
36	POLR2A	chr3:154799682-154800156	SK-N-SH	brain:	n/a	n/a
37	POLR2A	chr3:154798668-154798692	ProgFib	skin:	n/a	n/a
38	POLR2A	chr3:154801556-154801576	MCF10A-Er-Src	breast:	n/a	n/a
39	POLR2A	chr3:154800235-154800836	SK-N-SH	brain:	n/a	n/a
40	POLR2A	chr3:154798600-154798958	MCF10A-Er-Src	breast:	n/a	n/a
41	POLR2A	chr3:154799814-154799958	MCF10A-Er-Src	breast:	n/a	n/a
42	POLR2A	chr3:154801392-154802377	SK-N-SH	brain:	n/a	n/a
43	POLR2A	chr3:154798694-154798835	ProgFib	skin:	n/a	n/a
44	POLR2A	chr3:154800161-154800285	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr3:154800858-154801285	SK-N-SH	brain:	n/a	n/a
46	ZNF143	chr3:154798630-154798712	K562	blood:	n/a	n/a

Variant related genes	Relation type
MME	TF binding region

Extended variants
information (count: 129 )
Associated
traits (count: 51 )

Variant overlapped rSNPs/rCNVs (count:129 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs373731810	chr3:154798665-154798666	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs556024065	chr3:154798681-154798682	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs571149707	chr3:154798731-154798732	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs147730685	chr3:154798750-154798751	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs141017528	chr3:154798774-154798775	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs77464783	chr3:154798782-154798783	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs377377909	chr3:154798790-154798791	Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs192607654	chr3:154798847-154798848	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs369777711	chr3:154798860-154798861	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs76144601	chr3:154798863-154798864	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs369540090	chr3:154798932-154798933	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs560703648	chr3:154798947-154798948	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs112048731	chr3:154798962-154798963	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs113862233	chr3:154798965-154798966	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs532754123	chr3:154798977-154798978	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs150276165	chr3:154798991-154798992	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs546348224	chr3:154798994-154798995	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs560004847	chr3:154798996-154798997	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs566864501	chr3:154799030-154799031	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs571010599	chr3:154799073-154799074	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs184479584	chr3:154799090-154799091	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs566957852	chr3:154799111-154799112	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs531197301	chr3:154799119-154799120	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs549712116	chr3:154799142-154799143	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs189134038	chr3:154799149-154799150	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs377590198	chr3:154799156-154799157	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs111569217	chr3:154799159-154799160	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs535742606	chr3:154799179-154799180	Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs536783363	chr3:154799200-154799201	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs555087541	chr3:154799203-154799204	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs576549887	chr3:154799218-154799219	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs145847095	chr3:154799220-154799221	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs537393593	chr3:154799250-154799251	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs192613692	chr3:154799253-154799254	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs541285023	chr3:154799326-154799327	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs559922825	chr3:154799365-154799366	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs149002634	chr3:154799366-154799367	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs143671189	chr3:154799380-154799381	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs560646666	chr3:154799382-154799383	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs550354188	chr3:154799392-154799393	Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs111559479	chr3:154799406-154799407	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs79658174	chr3:154799407-154799408	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs200032779	chr3:154799420-154799421	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs138210899	chr3:154799487-154799488	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs74731178	chr3:154799519-154799520	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs184906592	chr3:154799530-154799531	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs189019121	chr3:154799532-154799533	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs532410119	chr3:154799553-154799554	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs568760038	chr3:154799592-154799593	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs565903793	chr3:154799597-154799598	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:51)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Neurodevelopmental disorder	22521361	CNVD
Bladder cancer	21909424	CNVD
Ovarian clear cell carcinoma	21343371	CNVD

Chromatin state (count:193 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:154796000-154802200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr3:154796200-154799600	Active TSS	ES-I3 Cell Line	embryonic stem cell
3	chr3:154796200-154799600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr3:154796400-154799000	Active TSS	Placenta Amnion	Placenta Amnion
5	chr3:154796400-154799200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
6	chr3:154796400-154800000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr3:154796400-154800000	Active TSS	NHLF	lung
8	chr3:154796600-154798800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
9	chr3:154796600-154798800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
10	chr3:154796600-154798800	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr3:154796600-154798800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr3:154796600-154798800	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
13	chr3:154796600-154799000	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
14	chr3:154796600-154799000	Active TSS	H9 Cell Line	embryonic stem cell
15	chr3:154796600-154799000	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
16	chr3:154796600-154799000	Active TSS	Placenta	Placenta
17	chr3:154796600-154799200	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr3:154796600-154800000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr3:154796600-154800200	Active TSS	Psoas Muscle	Psoas
20	chr3:154796600-154800600	Active TSS	Breast Myoepithelial Primary Cells	Breast
21	chr3:154796600-154802000	Active TSS	Duodenum Mucosa	Duodenum
22	chr3:154796800-154798800	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
23	chr3:154796800-154798800	Bivalent/Poised TSS	Fetal Intestine Large	intestine
24	chr3:154796800-154798800	Bivalent/Poised TSS	NH-A	brain
25	chr3:154796800-154799400	Active TSS	NHDF-Ad	bronchial
26	chr3:154796800-154799600	Active TSS	Muscle Satellite Cultured Cells	--
27	chr3:154796800-154801200	Active TSS	Fetal Kidney	kidney
28	chr3:154797000-154798800	Active TSS	H1 Cell Line	embryonic stem cell
29	chr3:154797000-154798800	Active TSS	HUES48 Cell Line	embryonic stem cell
30	chr3:154797000-154798800	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
31	chr3:154797000-154799000	Active TSS	HSMMtube	muscle
32	chr3:154797000-154799600	Active TSS	Skeletal Muscle Female	skeletal muscle
33	chr3:154797200-154799200	Active TSS	Dnd41	blood
34	chr3:154797200-154801000	Active TSS	Fetal Intestine Small	intestine
35	chr3:154797400-154798800	Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr3:154797400-154799000	Flanking Active TSS	Liver	Liver
37	chr3:154797800-154798800	Flanking Active TSS	Adipose Nuclei	Adipose
38	chr3:154797800-154799000	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
39	chr3:154797800-154799200	Flanking Active TSS	HMEC	breast
40	chr3:154798200-154798800	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr3:154798200-154798800	Active TSS	Brain Angular Gyrus	brain
42	chr3:154798200-154798800	Bivalent/Poised TSS	Fetal Brain Male	brain
43	chr3:154798200-154798800	Active TSS	Fetal Muscle Trunk	muscle
44	chr3:154798200-154798800	Active TSS	Fetal Stomach	stomach
45	chr3:154798200-154798800	Active TSS	Right Ventricle	heart
46	chr3:154798200-154799000	Flanking Active TSS	Primary B cells from cord blood	blood
47	chr3:154798200-154799000	Active TSS	Fetal Adrenal Gland	Adrenal Gland
48	chr3:154798200-154799000	Enhancers	K562	blood
49	chr3:154798200-154799200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr3:154798200-154800000	Active TSS	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links